Figure 2: Changes in body weight from baseline to the end of treatment at week 26 associated with the treatment policy estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Anti-Inflammatory Modulates inflammatory cytokines including TNF-alpha and IL-6, reducing chronic low-grade inflammation that accelerates aging
I threw 5,000 IUs into the mix and figured, well, it's not going to kill me, it'll bring my vitamin D levels up
Role of topical peptides in preventing or treating aged skin
10.1016/j.ccr.2011.01.038 15